Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity von Vaitaitis, Gisela M, Wagner, Jr, David H

Volltext

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells von Vaitaitis, Gisela M, Yussman, Martin G, Waid, Dan M, Wagner, Jr, David H

Volltext

Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15 von Vaitaitis, Gisela M., Wagner, David H.

Volltext

Are we aiming to miss in translational autoimmunity treatments? [version 2; peer review: 3 approved, 1 approved with reservations] von Vaitaitis, Gisela M, Wagner, David H

Volltext

842-P: A Novel Drug to Modulate Autoinflammation and Promote Glucose Control in Type 1 Diabetes Mellitus von WAGNER, DAVID H., VAITAITIS, GISELA M.

Volltext

Are we aiming to miss in translational autoimmunity treatments? [version 1; peer review: 3 approved, 1 approved with reservations] von Vaitaitis, Gisela M, Wagner, David H

Volltext

CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression von Vaitaitis, Gisela M, Wagner, David H

Volltext

High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity von Vaitaitis, Gisela M, Wagner, Jr, David H

Volltext

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes von Waid, Dan M., Vaitaitis, Gisela M., Pennock, Nathan D., Wagner, David H.

Volltext

Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY6 Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis von Vaitaitis, Gisela M., Wagner, David H.

Volltext

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes von Vaitaitis, Gisela M., Waid, Dan M., Yussman, Martin G., Wagner, David H.

Volltext

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor von Vaitaitis, Gisela M, Rihanek, Marynette, Alkanani, Aimon K, Waid, Dan M, Gottlieb, Peter A, Wagner, David H

Volltext

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter] von Vaitaitis, Gisela M., Olmstead, Michael H., Waid, Dan M., Carter, Jessica R., Wagner, David H.

Volltext

A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice von Vaitaitis, Gisela M., Olmstead, Michael H., Waid, Dan M., Carter, Jessica R., Wagner, David H.

Volltext

436-P: Reducing Autoinflammation: The Impact of T-Cell Deficiency on Atherosclerosis von SHEPHERD, ALYSSA J., YUSSMAN, MARTIN, WAGNER, DAVID H., VAITAITIS, JR., GISELA M.

Volltext

CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity von Vaitaitis, Gisela M., Wagner, David H.

Volltext

A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis von Vaitaitis, Gisela M., Yussman, Martin G., Wagner, David H.

Volltext

CD40 engagement of CD4+CD40+ T cells in a neo‐self antigen disease model ablates CTLA‐4 expression and indirectly impacts tolerance von Carter, Jessica, Vaitaitis, Gisela M., Waid, Dan M., Wagner, David H.

Volltext

An alternative role for Foxp3 as an effector T cell regulator controlled through CD40 von Vaitaitis, Gisela M, Carter, Jessica R, Waid, Dan M, Olmstead, Michael H, Wagner, Jr, David H

Volltext

Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY 6 Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis von Vaitaitis, Gisela M, Wagner, Jr, David H

Volltext